|Chemical name: Canagliflozin
Typical dosage: 300mg
Typical type: Tablet1
Invokana® is a medication typically used to treat type 2 diabetes. It is a brand name medication and is available as an oral tablet.
Invokana is a prescription medication that contains the active ingredient Canagliflozin. Invokana is taken once daily by mouth before the first meal of the day.
Invokana inhibits sodium-glucose cotransporter 2 (SGLT2) in the kidneys to prevent absorption of blood sugar.
The major side effects of Invokana include increased potassium levels in the blood, urinary tract infections, yeast infections and kidney abnormalities.
Yes! 57% of Medicare Advantage plans and Medicare Part D plans cover Invokana.1
Drug coverage may vary based on plan availability. You may be able to find Medicare Advantage plan options in your area that cover Invokana.
Find Medicare Advantage plans with drug coverageCompare Plans
Or call TTY Users: 711 24/7 to speak with a licensed insurance agent.
Your copay and deductible costs for any prescription drug can vary depending on what coverage stage you’re in.
|Deductible stage||Typical copay stage|
|Your deductible is the amount of money you must spend on covered drugs before your Medicare drug coverage starts paying its share of costs.
In the deductible stage, you’re responsible for the full cost of your prescription drugs.
Some Medicare prescription drug plans have a $0 deductible. Medicare drug plans cannot have a deductible more than $415 in 2019.
|After you meet your Part D deductible, you enter the initial coverage period.
During this phase (the typical copay stage), you pay a copayment (flat fee) or coinsurance (percentage) for your covered medications.
|$95 – $568||$25 – $568|
Invokana is used in conjunction with diet and exercise to improve blood sugar control.
In patients with established cardiac risk who are taking metformin, the addition of canagliflozin may be considered to reduce major cardiac events.
Invokana can lead to low blood sugar. Signs of low blood sugar include dizziness, headache, feeling sleepy or weak, shaking, a fast heartbeat, confusion, hunger or sweating. Call your doctor right away if you have any of these signs.
The incidence of kidney problems, broken bones and acidosis (too much acid in the blood) have occurred in patients taking Invokana. Stay hydrated to protect your kidneys and avoid dangerous activities that could increase the chance of injury.
Signs and symptoms of kidney problems include inability to pass urine, change in how much urine is passed, blood in the urine or noticeable weight gain.
Call your doctor if you have signs and symptoms of acidosis including confusion, fast breathing, fast heart rate, bad stomach pain, nausea, vomiting, shortness of breath or feeling tired or weak.
This article is for informational purposes only. It is not healthcare advice, treatment, or diagnosis. It is not an endorsement of or recommendation for this medication. Speak to your doctor or healthcare provider about your specific healthcare needs, including your prescription medications. Only take medication as directed by your doctor.
Coverage and costs of prescription medications will vary by Medicare plan. Not all plans are available in all areas.
Written by Hayden Gharibyar, Pharm.D.
Copyright © 2019 TZ Insurance Solutions LLC. All rights reserved.
1 GoodRx. Invokana. Retrieved May 2019, from www.goodrx.com/invokana.
2 Jacobson, Gretchen; et al. A Dozen Facts About Medicare Advantage. (Nov. 13, 2018). Kaiser Family Foundation. Retrieved from www.kff.org/medicare/issue-brief/a-dozen-facts-about-medicare-advantage.
MedicareAdvantage.com is a website owned and operated by TZ Insurance Solutions LLC. TZ Insurance Solutions LLC and TruBridge, Inc. represent Medicare Advantage Organizations and Prescription Drug Plans having Medicare contracts; enrollment in any plan depends upon contract renewal.
Plan availability varies by region and state. For a complete list of available plans, please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
Medicare has neither reviewed nor endorsed this information.